bay-41-8543 and Weight-Loss

Obesity is characterized by a positive energy balance and expansion of white adipose tissue (WAT). In contrast, brown adipose tissue (BAT) combusts energy to produce heat. Here we show that a small molecule stimulator (BAY 41-8543) of soluble guanylyl cyclase (sGC), which produces the second messenger cyclic GMP (cGMP), protects against diet-induced weight gain, induces weight loss in established obesity, and also improves the diabetic phenotype. Mechanistically, the haeme-dependent sGC stimulator BAY 41-8543 enhances lipid uptake into BAT and increases whole-body energy expenditure, whereas ablation of the haeme-containing β1-subunit of sGC severely impairs BAT function. Notably, the sGC stimulator enhances differentiation of human brown adipocytes as well as induces 'browning' of primary white adipocytes. Taken together, our data suggest that sGC is a potential pharmacological target for the treatment of obesity and its comorbidities.

Topics: Adipocytes; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Cells, Cultured; Drug Evaluation, Preclinical; Guanylate Cyclase; Humans; Lipid Metabolism; Male; Mice, Inbred C57BL; Morpholines; Obesity; Pyrimidines; Thermogenesis; Weight Loss